From: IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults
R2 | β (95% CI) | p value | |
---|---|---|---|
TFF3 + Model 1 | 0.063 | 0.036 (− 0.019; 0.90) | 0.20 |
GDF-15 + Model 1 | 0.062 | 0.11 (− 0.062;− 0.029) | 0.20 |
RARRES2 + Model 1 | 0.065 | 0.23 (0.0081;0.45) | 0.058 |
IGFBP-2 + Model 1 | 0.069 | − 0.18 (− 0.29;− 0.065) | 0.0022* |
CD166 + Model 1 | 0.062 | 0.18 (− 0.087;0.44) | 0.19 |
IGFBP-1 + Model 1 | 0.068 | − 0.10 (− 0.18;− 0.017) | 0.018* |
OPG + Model 1 | 0.061 | 0.091 (− 0.12;0.30) | 0.39 |
MMP-3 + Model 1 | 0.060 | − 0.0021 (− 0.12;0.12) | 0.98 |
AZU1 + Model 1 | 0.061 | − 0.029 (− 0.17;11) | 0.68 |
ST2 + Model 1 | 0.062 | − 0.014 (− 0.13;0.10) | 0.81 |
CCL15 + Model 1 | 0.12 (− 0.0069;0.25) | 0.062 |